Melisachew M Yeshi

MD

[Fouad Boulos @fouad_boulos]

Happy to share the news that our E-cadherin article received enough views to be a Top Viewed Article in Histopathology.

Read it here https://t.co/r02lExjV9J #TopViewedArticle @wileyinresearch
@RezaTaha_

[Fouad Boulos @fouad_boulos]

NOT a germinal center.

Beware high-grade invasive carcinoma with the (no longer recognized) medullary pattern. Lymphoepithelioma-like carcinoma is another somewhat quaint term used on occasion.

#breastpath

[Fouad Boulos @fouad_boulos]

When large nests of tumor surround a completely normal duct, they are much more likely to be invasive cancer or lymphovascular invasion than DCIS. A useful pattern to remember on a biopsy

#breastpath

[Fouad Boulos @fouad_boulos]

Sorry for the long silence. This is a quick in-house case I had to share.

Breast mass, 2 cm. High grade, central fibrosis, lymphoid infiltrate, ER/PR/HER2 negative. Classic TNBC. Correct?

Incorrect. History of melanoma, discovered by chance, not mentioned anywhere in the pathology requisition, casually buried in a random note.

How scared should we be? How often should we work-up triple-negative tumors in search of some odd metastatic lesion? How many of you would have worried about this and investigated it further in the absence of history? I certainly wouldn't have.

Good luck staying safe and cautious without spiraling down into the abyss of obsession and paranoia.

IHC: Melan-A

#melanoma #breastcancer #breastpath @washupathedu @washu_pathology

[Katrina Collins, MD || Pathologist @katcollmd]

#publicationalert #gupath
Check out our review focusing on practice-changing updates in bladder and prostate, read and share! @LiangChengMD @Shounak_Gupta @Human_Pathology

�� https://t.co/SyMpuDluix

[Melisachew M Yeshi @Mele_path]

@premcharles @VickeryJasmine https://t.co/E8wXqDDuPc

[Melisachew M Yeshi @Mele_path]

@thejourneymate I prefer dysplasia instead of metaplasia. 😊

[Melisachew M Yeshi @Mele_path]

@UEGJournal @drkeithsiau @LinkedIn @my_ueg @albrechtneesse @WileyHealth @WileyGlobal @NEJM @TheLancet @ESGE_news @EASLedu @Y_ECCO_IBD @AmerGastroAssn @EndoCollabcom @EurPancClub @OfficialPCA @DeMadaria @Bealoquebea @Samir_Grover @DCharabaty @AustinChiangMD @SWexner @LumirKunovsky @stevenbollipo @Gio_Marchegiani Done.

[Melisachew M Yeshi @Mele_path]

@metishewyilma @flyethiopian The patternless lighting and the different color of the lights looks like that of ADD.

[Melisachew M Yeshi @Mele_path]

@drkeithsiau It worked on me…..

[Melisachew M Yeshi @Mele_path]

@drkeithsiau But today United is playing at the Tottenham Hotspur stadium…;-)

[UPMC Pathology @UPMCPathology]

Congratulations to @UPMCPathology's Dr. Liron Pantanowitz (@PathPro), Dr. Hooman Rashidi, and Dr. Matthew Hanna on their recent series presented by @TheUSCAP and @ModernPathology!

[Melisachew M Yeshi @Mele_path]

@Selamawt_MD @ziad_zaatari @JMGardnerMD Right.

[Wondweson64 Alemu @_Wondweson64]

🔬Diagnosis & Bite sized Pearl | Previous Case!
🔱 The Rise of SCC in a MATURE CYSTIC TERATOMA
#BSTpath #Pathresidents #PathTwitter #pathx @Pathologists @Pathology_mcqs @AceMyPath

[JClinPath_BMJ @JClinPath_BMJ]

A teaching point from our Editors. How do you distinguish between intrapancreatic bile duct carcinoma and pancreatic ductal carcinoma? @samuel_reis

[Mai Elzieny @MaiElzieny]

In my training, I heard two different thought processes regarding how to approach signing out cases. I would like to hear from experienced pathologists which one they follow: Do you prefer knowing the pt’s hx before looking at the slide, or no hx?#PathX #PathTwitter #Pathology

[Sanjay Mukhopadhyay @smlungpathguy]

Like most things there is no one right answer but I like to see H&E without bias first.

[Saad Shots 📸 @saadShots]

Support my hustle with just a Retweet 🙏🏾